PNC Financial Services Group’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.4K Buy
12,521
+35
+0.3% +$119 ﹤0.01% 3420
2025
Q4
$40.6K Buy
12,486
+44
+0.4% +$148 ﹤0.01% 3328
2025
Q3
$35.7K Buy
12,442
+697
+6% +$1.78K ﹤0.01% 3371
2025
Q2
$28.3K Sell
11,745
-81
-0.7% -$170 ﹤0.01% 3406
2025
Q1
$26.1K Buy
11,826
+604
+5% +$2.39K ﹤0.01% 3421
2024
Q4
$61.2K Sell
11,222
-374
-3% -$2.41K ﹤0.01% 2976
2024
Q3
$96.4K Sell
11,596
-225
-2% -$1.95K ﹤0.01% 2692
2024
Q2
$84.6K Sell
11,821
-1,755
-13% -$15.2K ﹤0.01% 2725
2024
Q1
$118K Buy
13,576
+3,073
+29% +$20.8K ﹤0.01% 2517
2023
Q4
$68.8K Sell
10,503
-139
-1% -$898 ﹤0.01% 2805
2023
Q3
$106K Buy
10,642
+1,380
+15% +$15.2K ﹤0.01% 2532
2023
Q2
$115K Buy
9,262
+439
+5% +$5.92K ﹤0.01% 2560
2023
Q1
$124K Buy
8,823
+1,621
+23% +$23.3K ﹤0.01% 2439
2022
Q4
$103K Buy
7,202
+7,141
+11,707% +$112K ﹤0.01% 2545
2022
Q3
$1K Sell
61
-11
-15% -$276 ﹤0.01% 4336
2022
Q2
$3K Sell
72
-166
-70% -$5.26K ﹤0.01% 4120
2022
Q1
$8K Buy
238
+144
+153% +$4.83K ﹤0.01% 3886
2021
Q4
$4K Sell
94
-88
-48% -$3.56K ﹤0.01% 4026
2021
Q3
$8K Buy
182
+55
+43% +$2.68K ﹤0.01% 3815
2021
Q2
$5K Buy
+127
New +$4.92K ﹤0.01% 3885

Other funds holding MRVI

PNC Financial Services Group's MRVI Position: Q1 2026 in Review

PNC Financial Services Group increased its Maravai LifeSciences (MRVI) stake by 0.28% in Q1 2026, buying an estimated $119 and bringing the position to 12,521 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3420.

PNC Financial Services Group first reported a position in MRVI in Q2 2021 and has held it in 20 quarters since. The position peaked at $124K in Q1 2023. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • PNC Financial Services Group held 12,521 shares of Maravai LifeSciences worth $35.4K as of Q1 2026.
  • PNC Financial Services Group bought 35 Maravai LifeSciences shares in Q1 2026, an estimated $119.
  • Maravai LifeSciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3420 holding.
  • PNC Financial Services Group first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 20 quarters since.
  • PNC Financial Services Group's Maravai LifeSciences position peaked at $124K in Q1 2023.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.